| Biodistribution and non-linear gene expression of mRNA LNPs affected by delivery route and particle size J Di, Z Du, K Wu, S Jin, X Wang, T Li, Y Xu Pharmaceutical Research 39 (1), 105-114, 2022 | 65 | 2022 |
| When liposomes met antibodies: Drug delivery and beyond J Di, F Xie, Y Xu Advanced Drug Delivery Reviews 154, 151-162, 2020 | 64 | 2020 |
| Surface ligand valency and immunoliposome binding: when more is not always better H Li, J Di, B Peng, Y Xu, N Zhang Pharmaceutical Research 38 (9), 1593-1600, 2021 | 5 | 2021 |
| Liposomal T cell engager and re-director for tumor cell eradication in cancer immunotherapy F Xie, L Zhang, S Shi, A Zheng, J Di, S Jin, X Miao, F Wu, X Chen, ... MAbs 14 (1), 2115205, 2022 | 4 | 2022 |
| Multiphysics-Informed Pharmacokinetic Modeling of Systemic Exposure of Intramuscularly Injected LNPs J Di, K Wu, P Hou, CD Corpstein, Y Xu, T Li Molecular Pharmaceutics 20 (12), 6162-6168, 2023 | 2 | 2023 |
| Multiphysics modeling and simulation of local transport and absorption kinetics of intramuscularly injected lipid nanoparticles J Di, P Hou, CD Corpstein, K Wu, Y Xu, T Li Journal of Controlled Release 359, 234-243, 2023 | 1 | 2023 |
| Targeting Strategies for Site-Specific mRNA Delivery J Di, P Huang, X Chen Bioconjugate Chemistry, 2024 | | 2024 |
